T‐cell response to phytohemagglutinin in the interferon‐γ release assay as a potential biomarker for the response to immune checkpoint inhibitors in patients with non‐small cell lung cancer

BACKGROUND: Immune checkpoint inhibitors are a standard treatment for advanced lung cancer, although it remains important to identify biomarkers that can accurately predict treatment response. Immune checkpoint inhibitors enhance the antitumor T‐cell response, and interferon‐γ plays an important rol...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Thorac Cancer
Main Authors: Kamimaki, Chisato, Kobayashi, Nobuaki, Hirata, Momo, Somekawa, Kohei, Fukuda, Nobuhiko, Kubo, Sousuke, Katakura, Seigo, Teranishi, Shuhei, Watanabe, Keisuke, Horita, Nobuyuki, Hara, Yu, Yamamoto, Masaki, Kudo, Makoto, Piao, Hongmei, Kaneko, Takeshi
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley & Sons Australia, Ltd 2021
Assuntos:
Original Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8169292/
https://ncbi.nlm.nih.gov/pubmed/33943031
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13978
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares